tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Recce Pharmaceuticals Updates Buy-Back Date

Story Highlights
Recce Pharmaceuticals Updates Buy-Back Date

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has shared an update.

Recce Pharmaceuticals Ltd has announced an update regarding its selective buy-back of performance shares, identified by the ASX security code RCEAH. The update pertains to the date of the buy-back occurring, which has been changed from the initially notified date. This announcement could impact stakeholders by altering the timeline of the buy-back process, potentially affecting the company’s share structure and market perception.

The most recent analyst rating on (AU:RCE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Recce Pharmaceuticals Ltd. stock, see the AU:RCE Stock Forecast page.

More about Recce Pharmaceuticals Ltd.

Average Trading Volume: 114,779

Technical Sentiment Signal: Hold

Current Market Cap: A$128M

For an in-depth examination of RCE stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1